These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1711377

  • 1. Antibody conjugates with morpholinodoxorubicin and acid-cleavable linkers.
    Mueller BM, Wrasidlo WA, Reisfeld RA.
    Bioconjug Chem; 1990; 1(5):325-30. PubMed ID: 1711377
    [Abstract] [Full Text] [Related]

  • 2. New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity.
    Kaneko T, Willner D, Monkovíc I, Knipe JO, Braslawsky GR, Greenfield RS, Vyas DM.
    Bioconjug Chem; 1991; 2(3):133-41. PubMed ID: 1932212
    [Abstract] [Full Text] [Related]

  • 3. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.
    Greenfield RS, Kaneko T, Daues A, Edson MA, Fitzgerald KA, Olech LJ, Grattan JA, Spitalny GL, Braslawsky GR.
    Cancer Res; 1990 Oct 15; 50(20):6600-7. PubMed ID: 2208122
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates.
    King HD, Yurgaitis D, Willner D, Firestone RA, Yang MB, Lasch SJ, Hellström KE, Trail PA.
    Bioconjug Chem; 1999 Oct 15; 10(2):279-88. PubMed ID: 10077478
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
    Trail PA, Willner D, Lasch SJ, Henderson AJ, Greenfield RS, King D, Zoeckler ME, Braslawsky GR.
    Cancer Res; 1992 Oct 15; 52(20):5693-700. PubMed ID: 1382845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis of methotrexate-antibody conjugates by regiospecific coupling and assessment of drug and antitumor activities.
    Kralovec J, Spencer G, Blair AH, Mammen M, Singh M, Ghose T.
    J Med Chem; 1989 Nov 15; 32(11):2426-31. PubMed ID: 2810330
    [Abstract] [Full Text] [Related]

  • 14. Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide.
    Kerr DE, Senter PD, Burnett WV, Hirschberg DL, Hellström I, Hellström KE.
    Cancer Immunol Immunother; 1990 Nov 15; 31(4):202-6. PubMed ID: 2116231
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains.
    King HD, Dubowchik GM, Mastalerz H, Willner D, Hofstead SJ, Firestone RA, Lasch SJ, Trail PA.
    J Med Chem; 2002 Sep 12; 45(19):4336-43. PubMed ID: 12213074
    [Abstract] [Full Text] [Related]

  • 16. Conjugation of the monoclonal antibody 17-1A with the nitroacridine compound C921 with the poly-L-lysine as an intermediate agent.
    Paprocka M, Boratyński J, Duś D, Kuśnierczyk H, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1997 Sep 12; 45(4):343-9. PubMed ID: 9523011
    [Abstract] [Full Text] [Related]

  • 17. Improved antitumor effects of 3'-deamino-3'-morpholino derivatives of pirarubicin.
    Ajito K, Ikeda D, Nosaka C, Komuro K, Kondo S, Takeuchi T.
    J Antibiot (Tokyo); 1990 Nov 12; 43(11):1464-70. PubMed ID: 2272921
    [Abstract] [Full Text] [Related]

  • 18. BR96 conjugates of highly potent anthracyclines.
    King HD, Staab AJ, Pham-Kaplita K, Yurgaitis D, Firestone RA, Lasch SJ, Trail PA.
    Bioorg Med Chem Lett; 2003 Jul 07; 13(13):2119-22. PubMed ID: 12798317
    [Abstract] [Full Text] [Related]

  • 19. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
    Ulbrich K, Etrych T, Chytil P, Jelínková M, Ríhová B.
    J Control Release; 2003 Feb 21; 87(1-3):33-47. PubMed ID: 12618021
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.
    Braslawsky GR, Edson MA, Pearce W, Kaneko T, Greenfield RS.
    Cancer Res; 1990 Oct 15; 50(20):6608-14. PubMed ID: 2208123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.